Evolv Technology Reports Second Quarter Financial Results

— Company Raises Revenue Growth Outlook for 2025 to 27%-30% —

  • Q2'25 Revenue of $32.5 million, up 29% year-over-year
  • Q2'25 Ending ARR1 of $110.5 million, up 27% year-over-year
  • Q2'25 Net Loss of $(40.5) million, with Net Profit Margin of (125)%
  • Q2'25 Adjusted EBITDA2 of $2.0 million, with Adjusted EBITDA Margin2 of 6%
  • Q2'25 Cash Flow from Operations of $2.1 million vs. $(21.6) million in Q2'24

Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended June 30, 2025.

“Our second quarter results were marked by strong revenue growth, continued customer acquisition and expansion, and improved visibility that positions us well as we evolve into a more predictable and scalable business," said John Kedzierski, President and Chief Executive Officer of Evolv Technology. "We believe that surpassing 1,000 customers served—and having screened over 3 billion visitors to date—reflects the market’s growing trust in our solutions. Looking ahead, we’re encouraged by the opportunity in the AI-based security screening market and remain focused on delivering consistent, high-quality performance.”

Results for the Second Quarter of 2025

Total revenue for the second quarter of 2025 was $32.5 million, an increase of 29% compared to $25.2 million (as restated) for the second quarter of 2024. Annual Recurring Revenue (“ARR”)1 was $110.5 million at the end of second quarter of 2025, an increase of 27% compared to $87.0 million (as restated) at the end of the second quarter of 2024. Net loss for the second quarter of 2025 was $(40.5) million, or $(0.25) per basic and diluted share, compared to net income of $3.4 million (as restated), or $0.02 per basic and diluted share, in the second quarter of 2024. Adjusted earnings (loss)2 for the second quarter of 2025 was $(3.4) million, or $(0.02) per diluted share, compared to adjusted earnings (loss)2 of $(11.2) million (as restated), or $(0.07) per diluted share (as restated), for the second quarter of 2024. Adjusted EBITDA2 for the second quarter of 2025 was $2.0 million compared to $(8.0) million (as restated) in the second quarter of 2024. As of June 30, 2025, the Company had cash, cash equivalents and marketable securities of $36.9 million and no debt.

Results for the First Six Months of 2025

Total revenue for the six months ended June 30, 2025 was $64.6 million, an increase of 36% compared to $47.4 million (as restated) for the six months ended June 30, 2024. Net loss for the six months ended June 30, 2025 was $(42.2) million, or $(0.26) per basic and diluted share, compared to $(7.9) million (as restated), or $(0.05) per basic and diluted share, in the six months ended June 30, 2024. Adjusted earnings (loss)2 for the six months ended June 30, 2025 was $(6.8) million, or $(0.04) per diluted share, compared to adjusted earnings (loss)2 of $(23.9) million (as restated), or $(0.15) per diluted share (as restated), for the six months ended June 30, 2024. Adjusted EBITDA2 for the six months ended June 30, 2025 was $3.8 million compared to $(18.3) million (as restated) in the six months ended June 30, 2024.

The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

2025

 

2024

 

% Change

 

2025

 

2024

 

% Change

 

 

 

(Restated)

 

 

 

 

 

(Restated)

 

 

Recurring revenue

$

26,678

 

$

21,016

 

27

%

 

$

52,431

 

$

39,977

 

31

%

Non-recurring revenue

 

5,866

 

 

4,208

 

39

%

 

 

12,120

 

 

7,428

 

63

%

Total revenue

$

32,544

 

$

25,224

 

29

%

 

$

64,551

 

$

47,405

 

36

%

The following table summarizes operating cash flows for each period presented:

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

 

(Restated)

Net loss

$

(42,224

)

 

$

(7,854

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities

 

37,361

 

 

 

(10,672

)

Changes in operating assets and liabilities

 

4,437

 

 

 

(19,206

)

Net cash used in operating activities

$

(426

)

 

$

(37,732

)

Company Comments on Outlook for 2025

The Company today commented on its business outlook for 2025. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2025 to be between $132 to $135 million, reflecting growth of 27% to 30% compared to 2024. The Company believes that this revenue growth, coupled with a focus on operational efficiency, will drive improved profitability and cash flow. The Company expects to deliver positive full year Adjusted EBITDA1 in 2025 with Adjusted EBITDA1 margins in the mid-single digits. The Company expects to be cash flow positive in the fourth quarter of 2025.

Estimate

 

Issued May 20, 2025

 

Issued August 14, 2025

Total Revenue (Millions)

 

$125-$130

 

$132-$135

Total Revenue Growth Rate

 

20%-25%

 

27%-30%

Adjusted EBITDA Margin2

 

Low to Mid-Single Digits

 

Mid-Single Digits

Company to Host Live Conference Call and Webcast

The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com.

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than three billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) 2024 awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

2 Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, non-recurring restructuring and other employee separation costs, and non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the U.S. Federal Trade Commission investigation, net of estimated insurance recoveries. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, and non-recurring inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating loss is defined as operating loss, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, non-recurring restructuring and other employee separation costs, non-recurring inventory charges, and non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, non-recurring restructuring and other employee separation costs, non-recurring inventory charges, and non-recurring legal and regulatory costs. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, non-recurring restructuring and other employee separation costs, non-recurring inventory charges, and non-recurring legal and regulatory costs. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, market opportunities, and future financial and operational results. Words such as “believe” “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “project,” “plan,” “target,” “forecast”, “is/are likely to” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the “SEC”) and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on From 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share data)

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenue:

 

 

 

 

 

 

 

Product revenue

$

2,528

 

 

$

1,954

 

 

$

4,850

 

 

$

3,445

 

Subscription revenue

 

20,200

 

 

 

15,655

 

 

 

39,437

 

 

 

29,874

 

Service revenue

 

6,686

 

 

 

5,566

 

 

 

13,416

 

 

 

10,818

 

License fee and other revenue

 

3,130

 

 

 

2,049

 

 

 

6,848

 

 

 

3,268

 

Total revenue

 

32,544

 

 

 

25,224

 

 

 

64,551

 

 

 

47,405

 

Cost of revenue:

 

 

 

 

 

 

 

Cost of product revenue

 

5,351

 

 

 

2,839

 

 

 

8,535

 

 

 

5,953

 

Cost of subscription revenue

 

8,894

 

 

 

6,309

 

 

 

16,790

 

 

 

11,894

 

Cost of service revenue

 

1,710

 

 

 

1,147

 

 

 

3,415

 

 

 

2,345

 

Cost of license fee and other revenue

 

371

 

 

 

172

 

 

 

443

 

 

 

301

 

Total cost of revenue

 

16,326

 

 

 

10,467

 

 

 

29,183

 

 

 

20,493

 

Gross profit

 

16,218

 

 

 

14,757

 

 

 

35,368

 

 

 

26,912

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

4,737

 

 

 

5,850

 

 

 

9,599

 

 

 

12,246

 

Sales and marketing

 

11,736

 

 

 

16,357

 

 

 

22,779

 

 

 

32,216

 

General and administrative

 

17,238

 

 

 

14,061

 

 

 

32,210

 

 

 

25,867

 

Restructuring costs

 

 

 

 

860

 

 

 

2,662

 

 

 

860

 

Total operating expenses

 

33,711

 

 

 

37,128

 

 

 

67,250

 

 

 

71,189

 

Loss from operations

 

(17,493

)

 

 

(22,371

)

 

 

(31,882

)

 

 

(44,277

)

Other (expense) income, net:

 

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

(1

)

 

 

 

Interest income

 

224

 

 

 

681

 

 

 

613

 

 

 

1,766

 

Other income (expense), net

 

136

 

 

 

(39

)

 

 

161

 

 

 

(67

)

Change in fair value of contingent earn-out liability

 

(14,200

)

 

 

16,514

 

 

 

(5,224

)

 

 

23,413

 

Change in fair value of contingently issuable common stock liability

 

(3,900

)

 

 

3,747

 

 

 

(2,247

)

 

 

4,274

 

Change in fair value of public warrant liability

 

(5,303

)

 

 

4,886

 

 

 

(3,582

)

 

 

7,037

 

Total other (expense) income, net

 

(23,043

)

 

 

25,789

 

 

 

(10,280

)

 

 

36,423

 

(Loss) income before income taxes

 

(40,536

)

 

 

3,418

 

 

 

(42,162

)

 

 

(7,854

)

(Benefit) provision for income taxes

 

(1

)

 

 

 

 

$

62

 

 

$

 

Net (loss) income

$

(40,535

)

 

$

3,418

 

 

$

(42,224

)

 

$

(7,854

)

Net (loss) income attributable to common stockholders – basic and diluted

$

(40,535

)

 

$

3,377

 

 

$

(42,224

)

 

$

(7,854

)

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

 

 

 

Basic

 

165,252,554

 

 

 

156,473,080

 

 

 

163,042,749

 

 

 

154,774,899

 

Diluted

 

165,252,554

 

 

 

171,563,943

 

 

 

163,042,749

 

 

 

154,774,899

 

Net loss per share

 

 

 

 

 

 

 

Basic

$

(0.25

)

 

$

0.02

 

 

$

(0.26

)

 

$

(0.05

)

Diluted

$

(0.25

)

 

$

0.02

 

 

$

(0.26

)

 

$

(0.05

)

 

 

 

 

 

 

 

 

Net (loss) income

$

(40,535

)

 

$

3,418

 

 

$

(42,224

)

 

$

(7,854

)

Other comprehensive (loss) income

 

 

 

 

 

 

 

Cumulative translation adjustment

 

(85

)

 

 

8

 

 

 

(131

)

 

 

11

 

Total other comprehensive (loss) income

 

(85

)

 

 

8

 

 

 

(131

)

 

 

11

 

Total comprehensive (loss) income

$

(40,620

)

 

$

3,426

 

 

$

(42,355

)

 

$

(7,843

)

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

 

June 30, 2025

 

December 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

36,942

 

 

$

37,015

 

Marketable securities

 

 

 

 

14,927

 

Accounts receivable, net

 

41,802

 

 

 

28,392

 

Inventory

 

12,142

 

 

 

16,963

 

Current portion of contract assets

 

847

 

 

 

799

 

Current portion of commission asset

 

5,592

 

 

 

5,429

 

Prepaid expenses and other current assets

 

35,756

 

 

 

17,921

 

Total current assets

 

133,081

 

 

 

121,446

 

Contract assets, noncurrent

 

845

 

 

 

657

 

Commission asset, noncurrent

 

7,331

 

 

 

7,567

 

Property and equipment, net

 

125,478

 

 

 

123,661

 

Operating lease right-of-use assets

 

13,149

 

 

 

13,993

 

Other assets

 

538

 

 

 

735

 

Total assets

$

280,422

 

 

$

268,059

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

11,804

 

 

$

10,492

 

Accrued expenses and other current liabilities

 

38,170

 

 

 

19,508

 

Current portion of deferred revenue

 

72,164

 

 

 

64,506

 

Current portion of operating lease liabilities

 

2,716

 

 

 

2,203

 

Current portion of contingent earn-out liability

 

18,033

 

 

 

 

Total current liabilities

 

142,887

 

 

 

96,709

 

Deferred revenue, noncurrent

 

19,208

 

 

 

20,266

 

Operating lease liabilities, noncurrent

 

11,550

 

 

 

12,326

 

Contingent earn-out liability, non-current

 

 

 

 

12,809

 

Contingently issuable common stock liability

 

6,248

 

 

 

4,001

 

Public warrant liability

 

7,879

 

 

 

4,297

 

Total liabilities

 

187,772

 

 

 

150,408

 

 

 

 

 

Stockholders’ equity:

 

 

 

Preferred stock, $0.0001 par value; 100,000,000 authorized at June 30, 2025 and December 31, 2024; no shares issued and outstanding at June 30, 2025 and December 31, 2024

 

 

 

 

 

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at June 30, 2025 and December 31, 2024; 170,626,362 and 159,602,069 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively

 

17

 

 

 

16

 

Additional paid-in capital

 

489,684

 

 

 

472,331

 

Accumulated other comprehensive loss

 

(163

)

 

 

(32

)

Accumulated deficit

 

(396,888

)

 

 

(354,664

)

Stockholders’ equity

 

92,650

 

 

 

117,651

 

Total liabilities and stockholders’ equity

$

280,422

 

 

$

268,059

 

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

Net loss

$

(42,224

)

 

$

(7,854

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

11,318

 

 

 

7,358

 

Write-off of inventory and change in inventory reserve

 

1,794

 

 

 

1,725

 

Loss on disposal of property and equipment

 

1,633

 

 

 

 

Stock-based compensation

 

10,426

 

 

 

13,857

 

Amortization of premium on marketable securities, net of change in accrued interest

 

127

 

 

 

181

 

Non-cash lease expense

 

844

 

 

 

728

 

Change in allowance for expected credit losses

 

166

 

 

 

203

 

Change in fair value of earn-out liability

 

5,224

 

 

 

(23,413

)

Change in fair value of contingently issuable common stock

 

2,247

 

 

 

(4,274

)

Change in fair value of public warrant liability

 

3,582

 

 

 

(7,037

)

Changes in operating assets and liabilities

 

 

 

Accounts receivable

 

(13,325

)

 

 

(14,067

)

Inventory

 

6,141

 

 

 

(10,042

)

Commission assets

 

73

 

 

 

(521

)

Contract assets

 

(236

)

 

 

237

 

Other assets

 

197

 

 

 

337

 

Prepaid expenses and other current assets

 

(18,849

)

 

 

(2,957

)

Accounts payable

 

6,120

 

 

 

(1,653

)

Deferred revenue

 

6,205

 

 

 

10,271

 

Accrued expenses and other current liabilities

 

18,374

 

 

 

(46

)

Operating lease liability

 

(263

)

 

 

(765

)

Net cash used in operating activities

 

(426

)

 

 

(37,732

)

Cash flows from investing activities:

 

 

 

Development of internal-use software

 

(3,112

)

 

 

(3,112

)

Purchases of property and equipment

 

(15,299

)

 

 

(21,618

)

Purchases of marketable securities

 

(9,875

)

 

 

(14,567

)

Proceeds from maturities of marketable securities

 

24,675

 

 

 

44,918

 

Net cash (used in) provided by investing activities

 

(3,611

)

 

 

5,621

 

Cash flows from financing activities:

 

 

 

Proceeds from exercise of stock options

 

4,095

 

 

 

636

 

Net cash provided by financing activities

 

4,095

 

 

 

636

 

Effect of exchange rate changes on cash and cash equivalents

 

(131

)

 

 

11

 

Net decrease in cash, cash equivalents and restricted cash

 

(73

)

 

 

(31,464

)

Cash, cash equivalents and restricted cash

 

 

 

Cash, cash equivalents and restricted cash at beginning of period

 

37,015

 

 

 

67,437

 

Cash, cash equivalents and restricted cash at end of period

$

36,942

 

 

$

35,973

 

 

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

 

 

Three Months Ended or as of,

($ in thousands)

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

New customers

 

 

53

 

 

84

 

 

52

 

 

60

 

 

54

 

 

63

Annual recurring revenue

 

$

79,192

 

$

87,011

 

$

93,676

 

$

99,351

 

$

105,990

 

$

110,516

Recurring revenue

 

$

18,961

 

$

21,016

 

$

23,764

 

$

23,678

 

$

25,753

 

$

26,678

 

.

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands)

(Unaudited)

 

 

Three Months Ended,

 

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

 

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

Operating expenses, GAAP

 

$

34,061

 

 

$

37,128

 

 

$

34,961

 

 

$

35,619

 

 

$

33,539

 

 

$

33,711

 

Stock-based compensation

 

 

(6,292

)

 

 

(7,254

)

 

 

(7,263

)

 

 

(3,159

)

 

 

(4,660

)

 

 

(5,265

)

Loss on impairment of leased equipment

 

 

 

 

 

 

 

 

(209

)

 

 

(15

)

 

 

 

 

 

 

Non-recurring restructuring and other employee separation costs

 

 

 

 

 

(1,000

)

 

 

 

 

 

(2,060

)

 

 

(2,137

)

 

 

(827

)

Other non-recurring legal and regulatory costs

 

 

(476

)

 

 

(2,185

)

 

 

(2,339

)

 

 

(7,284

)

 

 

(3,561

)

 

 

(5,979

)

Adjusted operating expenses

 

$

27,293

 

 

$

26,689

 

 

$

25,150

 

 

$

23,101

 

 

$

23,181

 

 

$

21,640

 

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED INCOME (LOSS) FROM OPERATIONS

(In thousands)

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

(Restated)

 

 

 

(Restated)

Revenue

$

32,544

 

 

$

25,224

 

 

$

64,551

 

 

$

47,405

 

Cost of revenue

 

16,326

 

 

 

10,467

 

 

 

29,183

 

 

 

20,493

 

Gross profit, GAAP

 

16,218

 

 

 

14,757

 

 

 

35,368

 

 

 

26,912

 

Stock-based compensation

 

282

 

 

 

173

 

 

 

501

 

 

 

311

 

Amortization of capitalized stock-based compensation

 

107

 

 

 

15

 

 

 

210

 

 

 

29

 

Loss on disposal of leased equipment

 

1,255

 

 

 

 

 

 

1,255

 

 

 

 

Non-recurring restructuring and other employee separation costs

 

6

 

 

 

 

 

 

6

 

 

 

 

Non-recurring inventory charges

 

 

 

 

(68

)

 

 

 

 

 

1,136

 

Adjusted gross profit

$

17,868

 

 

$

14,877

 

 

$

37,340

 

 

$

28,388

 

 

 

 

 

 

 

 

 

Gross margin %

 

49.8

%

 

 

58.5

%

 

 

54.8

%

 

 

56.8

%

Adjusted gross margin %

 

54.9

%

 

 

59.0

%

 

 

57.8

%

 

 

59.9

%

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

(Restated)

 

 

 

(Restated)

Loss from operations, GAAP

$

(17,493

)

 

$

(22,371

)

 

$

(31,882

)

 

$

(44,277

)

Stock-based compensation

 

5,547

 

 

 

7,427

 

 

 

10,426

 

 

 

13,857

 

Amortization of capitalized stock-based compensation

 

107

 

 

 

15

 

 

 

210

 

 

 

29

 

Loss on disposal of leased equipment

 

1,255

 

 

 

 

 

 

1,255

 

 

 

 

Non-recurring restructuring and other employee separation costs

 

833

 

 

 

1,000

 

 

 

2,970

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

(68

)

 

 

 

 

 

1,136

 

Other non-recurring legal and regulatory costs

 

5,979

 

 

 

2,185

 

 

 

9,540

 

 

 

2,661

 

Adjusted loss from operations

$

(3,772

)

 

$

(11,812

)

 

$

(7,481

)

 

$

(25,594

)

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

(In thousands)

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

2025

 

2024

 

2025

 

2024

 

 

 

(Restated)

 

 

 

(Restated)

Net (loss) income

$

(40,535

)

 

$

3,418

 

 

$

(42,224

)

 

$

(7,854

)

Depreciation & amortization

 

5,788

 

 

 

3,901

 

 

 

11,318

 

 

 

7,358

 

Stock-based compensation

 

5,547

 

 

 

7,427

 

 

 

10,426

 

 

 

13,857

 

Interest expense (income)

 

(224

)

 

 

(681

)

 

 

(612

)

 

 

(1,766

)

Provision for income taxes

 

(1

)

 

 

 

 

 

62

 

 

 

 

Change in fair value of contingent earn-out liability

 

14,200

 

 

 

(16,514

)

 

 

5,224

 

 

 

(23,413

)

Change in fair value of contingently issuable common stock liability

 

3,900

 

 

 

(3,747

)

 

 

2,247

 

 

 

(4,274

)

Change in fair value of public warrant liability

 

5,303

 

 

 

(4,886

)

 

 

3,582

 

 

 

(7,037

)

Loss on disposal of leased equipment

 

1,255

 

 

 

 

 

 

1,255

 

 

 

 

Non-recurring restructuring and other employee separation costs

 

833

 

 

 

1,000

 

 

 

2,970

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

(68

)

 

 

 

 

 

1,136

 

Other non-recurring legal and regulatory costs

 

5,979

 

 

 

2,185

 

 

 

9,540

 

 

 

2,661

 

Adjusted EBITDA

$

2,045

 

 

$

(7,965

)

 

$

3,788

 

 

$

(18,332

)

 

 

 

 

 

 

 

 

Net profit margin %

 

(124.6

)%

 

 

13.6

%

 

 

(65.4

)%

 

 

(16.6

)%

Impact of adjustments from Net loss to Adjusted EBITDA

 

130.8

%

 

 

(45.2

)%

 

 

71.3

%

 

 

(22.1

)%

Adjusted EBITDA margin %

 

6.3

%

 

 

(31.6

)%

 

 

5.9

%

 

 

(38.7

)%

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

(In thousands, except share and per share data)

(Unaudited)

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

(Restated)

 

 

 

(Restated)

Net (loss) income

$

(40,535

)

 

$

3,418

 

 

$

(42,224

)

 

$

(7,854

)

Stock-based compensation

 

5,547

 

 

 

7,427

 

 

 

10,426

 

 

 

13,857

 

Amortization of capitalized stock-based compensation

 

107

 

 

 

15

 

 

 

210

 

 

 

29

 

Change in fair value of contingent earn-out liability

 

14,200

 

 

 

(16,514

)

 

 

5,224

 

 

 

(23,413

)

Change in fair value of contingently issuable common stock liability

 

3,900

 

 

 

(3,747

)

 

 

2,247

 

 

 

(4,274

)

Change in fair value of public warrant liability

 

5,303

 

 

 

(4,886

)

 

 

3,582

 

 

 

(7,037

)

Loss on disposal of leased equipment

 

1,255

 

 

 

 

 

 

1,255

 

 

 

 

Non-recurring restructuring and other employee separation costs

 

833

 

 

 

1,000

 

 

 

2,970

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

(68

)

 

 

 

 

 

1,136

 

Other non-recurring legal and regulatory costs

 

5,979

 

 

 

2,185

 

 

 

9,540

 

 

 

2,661

 

Adjusted loss

$

(3,411

)

 

$

(11,170

)

 

$

(6,770

)

 

$

(23,895

)

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – diluted

 

165,252,554

 

 

 

171,563,943

 

 

 

163,042,749

 

 

 

154,774,899

 

 

 

 

 

 

 

 

 

Adjusted loss per share – diluted

$

(0.02

)

 

$

(0.07

)

 

$

(0.04

)

 

$

(0.15

)

 

*Stock-based compensation, amortization of capitalized stock-based compensation, and non-recurring restructuring and other employee separation costs were recorded in the condensed consolidated statements of operations and comprehensive loss (income) as follows. Prior period amounts are being shown for comparative purposes:

 

Three Months Ended,

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

$

 

$

5

 

$

4

 

$

8

 

 

$

8

 

$

17

Cost of subscription revenue

 

91

 

 

110

 

 

169

 

 

154

 

 

 

137

 

 

167

Cost of service revenue

 

44

 

 

51

 

 

63

 

 

61

 

 

 

67

 

 

74

Cost of license fee and other revenue

 

3

 

 

7

 

 

8

 

 

10

 

 

 

7

 

 

24

Research and development

 

902

 

 

1,222

 

 

1,243

 

 

1,153

 

 

 

1,115

 

 

1,154

Sales and marketing

 

2,959

 

 

2,724

 

 

2,516

 

 

2,747

 

 

 

1,048

 

 

1,710

General and administrative

 

2,431

 

 

3,308

 

 

3,504

 

 

(741

)

 

 

1,972

 

 

2,401

Restructuring costs

 

 

 

 

 

 

 

 

 

 

525

 

 

Total stock-based compensation

$

6,430

 

$

7,427

 

$

7,507

 

$

3,392

 

 

$

4,879

 

$

5,547

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of capitalized stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

Cost of subscription revenue

$

8

 

$

8

 

$

13

 

$

47

 

 

$

59

 

$

60

Cost of service revenue

 

6

 

 

7

 

 

10

 

 

38

 

 

 

44

 

 

47

Total amortization of capitalized stock-based compensation

$

14

 

$

15

 

$

23

 

$

85

 

 

$

103

 

$

107

 

 

 

 

 

 

 

 

 

 

 

 

Non-recurring restructuring and other employee separation costs:

 

 

 

 

 

 

 

 

 

 

 

Cost of service revenue

$

 

$

 

$

 

$

 

 

$

 

$

6

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

31

Sales and marketing

 

 

 

140

 

 

 

 

63

 

 

 

 

 

613

General and administrative

 

 

 

 

 

 

 

1,997

 

 

 

 

 

183

Restructuring costs

 

 

 

860

 

 

 

 

 

 

 

2,137

 

 

Total non-recurring restructuring and other employee separation costs

$

 

$

1,000

 

$

 

$

2,060

 

 

$

2,137

 

$

833

 

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.